GoConqr has a new look! Let us know what you think.

Sign up free

Quiz

L16 Therapeutics of Asthma

Deleted user 8 questions Updated 26 May 2019

Take the quiz

This quiz has question types that open in the usual player.

Questions in this quiz (8)

  1. 1Clinical practice guidelines, meta-analysis, and systematic reviews are the highest ranked forms of evidence.
    1. ATrue
    2. BFalse
  2. 2Māori are 3.4 times, and Pacific peoples 3.9 times, more likely to be admitted to hospital with asthma than Europeans or other New Zealanders.
    1. ATrue
    2. BFalse
  3. 3When diagnosing asthma there is no single “gold standard” test, and we must assess the pattern of [blank_start]signs and symptoms[blank_end](wheezing, breathlessness, chest tightness, and coughing, particularly at [blank_start]night[blank_end] or [blank_start]early[blank_end] in the morning). We can also measure [blank_start]expiratory airflow[blank_end] on more than one occasion, and assess [blank_start]response[blank_end] to inhaled bronchodilator +/- inhaled corticosteroid.
    1. Asigns and symptoms
    2. Bnight
    3. Cearly
    4. Dexpiratory airflow
    5. Eresponse
  4. 4Ideal PEFR values depend on height and sex.
    1. ATrue
    2. BFalse
  5. 5Which of these is NOT a principle of asthma treatment?
    1. AAvoid triggers
    2. BMaking an asthma plan
    3. CDrugs to improve ventilation
    4. DDrugs to decrease inflammation
    5. EAvoid exercise
  6. 6Goals of asthma treatment are about maintaining long-term control using the [blank_start]least[blank_end] amount of medications and [blank_start]minimising[blank_end] adverse effects.
    We want to prevent chronic [blank_start]symptoms[blank_end], require infrequent use ([blank_start]2[blank_end] or fewer days/week) of SABA, maintain normal or near-normal [blank_start]pulmonary[blank_end] function and maintain [blank_start]activity[blank_end] levels. We should assure patients’ and families’ [blank_start]satisfaction[blank_end] with asthma care. We also want to prevent exacerbations, the need for [blank_start]hospitalisation[blank_end], and prevent progressive [blank_start]loss[blank_end] of lung function.
    1. Aleast
    2. Bminimising
    3. Csymptoms
    4. D2
    5. Epulmonary
    6. Factivity
    7. Gsatisfaction
    8. Hhospitalisation
    9. Iloss
  7. 7Which of these is not a drug delivery device?
    1. ASoft mist inhaler (SMI) - only with LAMA products in NZ
    2. BNebuliser
    3. CDry power inhaler (DPI)
    4. DMetered-dose inhaler (MDI) - spacer chamber
    5. EDry mist inhaler (DMI)
  8. 8Treatment steps:
    1. At initial diagnosis, all patients should use a [blank_start]SABA[blank_end], as required..
    2. Add an [blank_start]ICS[blank_end] if patients have symptoms for more than [blank_start]two[blank_end] weeks. Often a big decision! (The usual dose in adults is [blank_start]budesonide 400 mcg[blank_end]/day.)
    3. If control is not adequate, [blank_start]ICS dose[blank_end] can be increased.
    4. If control is not adequate, combine [blank_start]ICS with a LABA[blank_end]. ([blank_start]Formoterol+budesonide[blank_end] can be used as a preventer and replace SABA.)

    Patients can step up or down in order to achieve and maintain control.
    Check adherence and inhaler [blank_start]technique[blank_end] at each step of the way!
    1. ASABA
    2. BICS
    3. Ctwo
    4. Dbudesonide 400 mcg
    5. EICS dose
    6. FICS with a LABA
    7. GFormoterol+budesonide
    8. Htechnique

Information

Description
User has deleted their subject information Quiz on L16 Therapeutics of Asthma, created by Deleted user on 14/04/2019.
Author
Deleted user
Language
English
Views
57
History
Created on 14 Apr 2019 · updated on 26 May 2019
Rating
No ratings yet
Rate this quiz
Rate this quiz

Feedback

What is it about?

What do you think of the new look?

How do you like it?